Clavulanate

BRAND NAMES

1. Augmentin 

2. Augmentin Duo 

3. Augmentin ES 

4. Clavam

MECHANISM OF ACTION

Clavulanate (clavulanic acid) acts as a beta-lactamase inhibitor that enhances the effectiveness of beta-lactam antibiotics. Many bacteria produce beta-lactamase enzymes that inactivate antibiotics like Amoxicillin by breaking their beta-lactam ring. Clavulanate, having a similar structure, binds to these enzymes and acts as a suicide inhibitor, irreversibly inactivating them. This prevents the destruction of the antibiotic, allowing it to bind to penicillin-binding proteins (PBPs), inhibit bacterial cell wall synthesis, and ultimately cause bacterial cell death.

PHARMACOKINETICS

Absorption

Clavulanate (clavulanic acid), when administered orally in combination with Amoxicillin, is well absorbed from the gastrointestinal tract. It has good oral bioavailability, and absorption is generally improved when taken at the start of a meal, which also helps reduce gastrointestinal side effects. Peak plasma concentrations are typically reached within about 1 hour after ingestion.

Distribution

Clavulanate (clavulanic acid), when administered with Amoxicillin, has a moderate volume of distribution, indicating that it distributes well into body tissues and fluids. It penetrates effectively into respiratory tract tissues, middle ear fluid, sinus secretions, and urine, making it useful for treating infections in these areas.

Metabolism

Clavulanate (clavulanic acid), when given with Amoxicillin, undergoes partial metabolism in the liver. It is biotransformed into several inactive metabolites. Unlike amoxicillin, which is largely excreted unchanged, clavulanate is more extensively metabolized, with only a small proportion remaining unchanged in the body.

Elimination

Clavulanate (clavulanic acid), when administered with Amoxicillin, is eliminated primarily through the kidneys. It is excreted via urine as both unchanged drug and metabolites.

PHARMACODYNAMICS

Clavulanate (clavulanic acid) exhibits its pharmacodynamic effect primarily as a beta-lactamase inhibitor, enhancing the antibacterial activity of beta-lactam antibiotics such as Amoxicillin. By irreversibly binding to beta-lactamase enzymes produced by resistant bacteria, clavulanate prevents the enzymatic degradation of the antibiotic, thereby restoring its ability to inhibit bacterial cell wall synthesis.

ADMINISTRATION

Clavulanate is administered only in combination with a beta-lactam antibiotic, most commonly Amoxicillin, as it has minimal standalone antibacterial activity. It is usually given orally as tablets, chewable tablets, or suspension, and in more severe infections it may be administered intravenously in hospital settings. Oral formulations are best taken at the start of a meal to improve absorption and reduce gastrointestinal side effects such as nausea and diarrhea.

DOSAGE AND STRENGTH

Clavulanate is not administered alone and is always given in combination with Amoxicillin, with dosage expressed based on the amoxicillin content along with a fixed amount of clavulanate. Common adult oral strengths include 250 mg/125 mg, 500 mg/125 mg, and 875 mg/125 mg, while pediatric formulations are available as suspensions such as 600 mg/42.9 mg per 5 mL (ES formulation). The usual adult dosage varies depending on infection severity, commonly given every 8–12 hours.

DRUG INTERACTIONS

Clavulanate, when combined with Amoxicillin, may interact with several drugs, although most interactions are primarily due to the amoxicillin component. Concurrent use with probenecid can decrease renal tubular secretion, leading to increased and prolonged levels of amoxicillin and clavulanate in the blood. When used with oral anticoagulants such as warfarin, it may enhance the anticoagulant effect, increasing the risk of bleeding, so monitoring of INR is recommended.

FOOD INTERACTIONS

Clavulanate, when given in combination with Amoxicillin, has minimal clinically significant food interactions; however, food—especially meals—can influence its tolerability and absorption. Taking the medication at the start of a meal improves gastrointestinal absorption of clavulanate and reduces the likelihood of side effects such as nausea, vomiting, and abdominal discomfort.

CONTRAINDICATIONS

Clavulanate is contraindicated in patients with a known hypersensitivity to clavulanate, penicillins, or other beta-lactam antibiotics, including a history of severe allergic reactions such as anaphylaxis or angioedema to Amoxicillin or related drugs. It is also contraindicated in individuals with a previous history of cholestatic jaundice or hepatic dysfunction associated with amoxicillin-clavulanate use.

SIDE EFFECTS

1. Diarrhea (most common) 

2. Nausea 

3. Vomiting 

4. Abdominal pain.

OVER DOSAGE

Overdose of clavulanate, usually in combination with Amoxicillin, most commonly leads to gastrointestinal symptoms such as severe nausea, vomiting, abdominal pain, and diarrhea.

TOXICITY

Clavulanate toxicity is usually observed when it is administered in excess or in combination with Amoxicillin. The most common toxic effects involve the gastrointestinal system, including severe nausea, vomiting, abdominal pain, and profuse diarrhea, which may lead to dehydration and electrolyte imbalance.